EMV Capital (AIM:EMVC), a venture capital group specialising in deep tech and life sciences, has hailed the successful £1 million fundraising for Wanda Connected Health Systems.
Wanda, a leading platform in remote patient monitoring (RPM) and virtual care, helps healthcare providers detect and manage health issues early, improving outcomes and reducing costs.
The fundraising round, led by EMV Capital (AIM:EMVC) Partners, has increased EMV’s equity stake in Wanda Health to 21.9%, valued at £1.35 million — an impressive return on EMV’s initial investment of £62,000 earlier this year.
Additionally, third-party investors introduced by EMV have contributed managed assets worth £1.1 million.
The new investment will enable Wanda to advance its growth strategy, including developing AI algorithms to predict health risks, expanding into the US market, and pursuing regulatory approval for innovative cardiovascular risk indicators.
The company, a spinout from UCLA, recently partnered with the COPD Foundation, enhancing its ability to monitor the chronic lung condition.